Hims and Hers Health Inc vs Orion Office REIT Inc — how do they compare? Hims and Hers Health Inc trades at $29.1 (market cap $6.55B), while Orion Office REIT Inc trades at $2.19 (market cap $125.50M). The key difference: Hims and Hers Health Inc is far larger — about 52.2× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.64% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Orion Office REIT Inc for 33 Days on average.
| HIMS | ONL | |
|---|---|---|
Market Cap | $6.55B | $125.50M |
Volume | 14,842,814 | 303,276 |
Sector | Health | Real Estate |
52-Week High | $62.76 | $3.00 |
52-Week Low | $14.52 | $1.93 |
Typical Hold Time | 21 Days | 33 Days |
Enterprise Value | $7.25B | $542.43M |
Dividend Yield | — | 3.64% |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
ONL trades at $2.27, down 2.58% today, with a bearish technical signal from moving averages but bullish oscillators. The company shows declining revenue from $208M in 2022 to $148M in 2025, with persistent net losses widening to -$139M. Analyst consensus is split 50/50 buy/hold, while recent news highlights strategic portfolio repositioning and Q2 2026 earnings beat.
Outlook remains challenged by negative profitability and high debt levels, though low P/B of 0.2 suggests deep value. Key risks include office sector headwinds and cash flow volatility. Investment appeal hinges on successful execution of turnaround strategy amid weak fundamental trends.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →